Skip Navigation

Gates Foundation adopts open access policy for all its funded research

The Bill & Melinda Gates Foundation is adopting an Open Access policy which requires all of the research it funds to be published in a manner that is free for the public to use, including any underlying data sets.

Policy brief on malaria diagnostics in low-transmission settings

This policy brief by WHO's Global Malaria Programme provides a list of recommendations on the role, characteristics, performance and applications of malaria RDTs in low-transmission areas.

Multimedia section

Watch videos, browse a prezi and listen to podcasts with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

Malaria research publications

Browse through more than 70 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.